Sign Up
OverviewAPI
Anavex Life Sciences Corp. faces a class action lawsuit from Bronstein, Gewirtz & Grossman, LLC, accusing the company of violating securities laws through deceptive practices, resulting in a stock price decline. The lawsuit centers on Anavex's blarcamesine drug trials for CNS disorders, raising concerns about misrepresented trial outcomes and statistical methods.

Ask a question